Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
COVID-19-gerelateerde ARDS-subgroepen, verschillende respons op corticosteroïden
dec 2021 | Pneumonie, Virale infecties